Greedy Insider · Filing
RAPP · Buy · HEALY JAMES
HEALY JAMES (Director) bought 952,380 shares of Rapport Therapeutics, Inc. (RAPP) at $21.00, about $20M, on Oct 28, 2026, filed with the SEC on Oct 30, 2026.
Greediness Score 85 · Strong · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001104659-26-120789